Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,222,439
  • Shares Outstanding, K 390,734
  • Annual Sales, $ 3,236 M
  • Annual Income, $ -3,561 M
  • EBIT $ -3,463 M
  • EBITDA $ -3,369 M
  • 60-Month Beta 1.17
  • Price/Sales 6.97
  • Price/Cash Flow N/A
  • Price/Book 1.44

Options Overview Details

View History
  • Implied Volatility 74.17% (+3.07%)
  • Historical Volatility 77.85%
  • IV Percentile 65%
  • IV Rank 39.88%
  • IV High 104.55% on 04/08/25
  • IV Low 54.03% on 08/06/25
  • Expected Move (DTE 3) 2.23 (5.62%)
  • Put/Call Vol Ratio 0.36
  • Today's Volume 140,966
  • Volume Avg (30-Day) 75,537
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 1,073,062
  • Open Int (30-Day) 1,035,540
  • Expected Range 37.37 to 41.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -2.79
  • Number of Estimates 9
  • High Estimate -2.33
  • Low Estimate -3.15
  • Prior Year -2.50
  • Growth Rate Est. (year over year) -11.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.66 +38.17%
on 12/15/25
39.71 -0.28%
on 01/13/26
+10.14 (+34.42%)
since 12/12/25
3-Month
22.28 +77.74%
on 11/21/25
39.71 -0.28%
on 01/13/26
+12.86 (+48.09%)
since 10/13/25
52-Week
22.28 +77.74%
on 11/21/25
45.40 -12.78%
on 01/24/25
+4.45 (+12.66%)
since 01/13/25

Most Recent Stories

More News
Asian benchmarks are mixed after Wall Street pulls back and global uncertainty grows

Asian shares are trading mixed after Wall Street pulled back from its recent records and as political uncertainty brewed in various regions, including in Iran

AAPL : 261.05 (+0.31%)
JPM : 310.90 (-4.19%)
$SPX : 6,963.74 (-0.19%)
$DOWI : 49,191.99 (-0.80%)
MRNA : 39.60 (+17.02%)
$IUXX : 25,741.95 (-0.18%)
Wall Street pulls back from its records as JPMorgan Chase and Delta kick off earnings season

Wall Street pulled back from its records following a mixed start to the latest profit reporting season for big U.S. companies

SYF : 78.06 (-1.97%)
GOOGL : 335.97 (+1.24%)
AAPL : 261.05 (+0.31%)
$SPX : 6,963.74 (-0.19%)
JPM : 310.90 (-4.19%)
CAH : 208.26 (+2.83%)
$IUXX : 25,741.95 (-0.18%)
AXP : 358.00 (-0.44%)
$DOWI : 49,191.99 (-0.80%)
CME : 268.45 (+1.31%)
CMG : 39.41 (-2.31%)
MRNA : 39.60 (+17.02%)
Stocks Fall on Weakness in Software and Credit Card Companies

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.80%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.18%. March E-mini...

GOOGL : 335.97 (+1.24%)
INTU : 605.28 (-4.75%)
JPM : 310.90 (-4.19%)
$IUXX : 25,741.95 (-0.18%)
ZNH26 : 112-075 (-0.03%)
MSFT : 470.67 (-1.36%)
ESH26 : 6,990.75 (-0.16%)
MA : 544.99 (-3.76%)
V : 327.88 (-4.46%)
AMD : 220.97 (+6.39%)
$DOWI : 49,191.99 (-0.80%)
CMG : 39.41 (-2.31%)
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference

Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings Call

MRNA : 39.60 (+17.02%)
3 Unprofitable Stocks We Keep Off Our Radar

3 Unprofitable Stocks We Keep Off Our Radar

MODG : 14.15 (-0.14%)
HAS : 86.87 (+0.27%)
MRNA : 39.60 (+17.02%)
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010

MRNA : 39.60 (+17.02%)
1 Mooning Stock to Own for Decades and 2 We Find Risky

1 Mooning Stock to Own for Decades and 2 We Find Risky

NXDR : 1.9800 (unch)
MRNA : 39.60 (+17.02%)
DASH : 217.40 (+1.18%)
Why Is Moderna (MRNA) Stock Rocketing Higher Today

Why Is Moderna (MRNA) Stock Rocketing Higher Today

MRNA : 39.60 (+17.02%)
Why Moderna (MRNA) Stock Is Up Today

Why Moderna (MRNA) Stock Is Up Today

MRNA : 39.60 (+17.02%)
CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure

MRNA : 39.60 (+17.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 47.18
2nd Resistance Point 43.45
1st Resistance Point 41.52
Last Price 39.60
1st Support Level 35.86
2nd Support Level 32.13
3rd Support Level 30.20

See More

52-Week High 45.40
Last Price 39.60
Fibonacci 61.8% 36.57
Fibonacci 50% 33.84
Fibonacci 38.2% 31.11
52-Week Low 22.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar